| The consensus molecular subtypes of colorectal cancer J Guinney, R Dienstmann, X Wang, A De Reyniès, A Schlicker, ... Nature medicine 21 (11), 1350-1356, 2015 | 2130 | 2015 |
| Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective … W De Roock, B Claes, D Bernasconi, J De Schutter, B Biesmans, ... The lancet oncology 11 (8), 753-762, 2010 | 2088 | 2010 |
| Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ... Journal of the National Cancer Institute 98 (4), 262-272, 2006 | 1885 | 2006 |
| Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ... Journal of the National Cancer Institute 98 (17), 1183-1192, 2006 | 1335 | 2006 |
| Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 … AD Roth, S Tejpar, M Delorenzi, P Yan, R Fiocca, D Klingbiel, D Dietrich, ... Journal of clinical oncology 28 (3), 466-474, 2010 | 1108 | 2010 |
| 70-gene signature as an aid to treatment decisions in early-stage breast cancer F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ... New England Journal of Medicine 375 (8), 717-729, 2016 | 1005 | 2016 |
| Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ... Clinical cancer research 13 (11), 3207-3214, 2007 | 990 | 2007 |
| Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures P Wirapati, C Sotiriou, S Kunkel, P Farmer, S Pradervand, B Haibe-Kains, ... Breast Cancer Research 10 (4), R65, 2008 | 874 | 2008 |
| Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade S Loi, B Haibe-Kains, C Desmedt, F Lallemand, AM Tutt, C Gillet, P Ellis, ... Journal of clinical oncology 25 (10), 1239, 2007 | 841 | 2007 |
| A comparison of methods for differential expression analysis of RNA-seq data C Soneson, M Delorenzi BMC bioinformatics 14 (1), 91, 2013 | 831 | 2013 |
| Identification of molecular apocrine breast tumours by microarray analysis P Farmer, H Bonnefoi, V Becette, M Tubiana-Hulin, P Fumoleau, ... Breast Cancer Research 7 (2), 1-1, 2005 | 816 | 2005 |
| Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes C Desmedt, B Haibe-Kains, P Wirapati, M Buyse, D Larsimont, ... Clinical cancer research 14 (16), 5158-5165, 2008 | 795 | 2008 |
| Regional and cellular gene expression changes in human Huntington's disease brain A Hodges, AD Strand, AK Aragaki, A Kuhn, T Sengstag, G Hughes, ... Human molecular genetics 15 (6), 965-977, 2006 | 722 | 2006 |
| The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models MaQC Consortium Nature biotechnology 28 (8), 827, 2010 | 684 | 2010 |
| Stem cell-related" self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma A Murat, E Migliavacca, T Gorlia, WL Lambiv, T Shay, MF Hamou, ... Journal of clinical oncology 26 (18), 3015-24, 2008 | 660 | 2008 |
| A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer P Farmer, H Bonnefoi, P Anderle, D Cameron, P Wirapati, V Becette, ... Nature medicine 15 (1), 68-74, 2009 | 594 | 2009 |
| Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy A Sistigu, T Yamazaki, E Vacchelli, K Chaba, DP Enot, J Adam, I Vitale, ... Nature medicine 20 (11), 1301-1309, 2014 | 585 | 2014 |
| An HMM model for coiled-coil domains and a comparison with PSSM-based predictions M Delorenzi, T Speed Bioinformatics 18 (4), 617-625, 2002 | 426 | 2002 |
| Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features E Missiaglia, B Jacobs, G D'ario, AF Di Narzo, C Soneson, E Budinska, ... Annals of oncology 25 (10), 1995-2001, 2014 | 390 | 2014 |
| Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen S Loi, B Haibe-Kains, C Desmedt, P Wirapati, F Lallemand, AM Tutt, ... BMC genomics 9 (1), 239, 2008 | 368 | 2008 |
Christos SotiriouUniversité Libre de BruxellesVerified email at bordet.be
